Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Modification of (4S,5R)-3-Benzoyl-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic Acid which has similar potent cytotoxic activities in MCF-7 human tumor cell line as paclitaxel.
?您的位置：
